The purpose of this study is to assess the clinical performance of DAILIES TOTAL1® spherical soft contact lenses over approximately 1 week of daily wear.

Subjects will be expected to attend 2 visits (Visit 1 Screen/Baseline/ Dispense; and Visit 2 Week 1 Follow-up/ Exit). The total duration of a subject's participation in the study as well as exposure to the contact lenses will be approximately 1 week (6-8 days of contact lens wear).

Key Inclusion Criteria:

• Current wearer of commercial spherical soft contact lenses in both eyes with at least 3 months of wearing experience, with a minimum wearing time of 5 days per week and 10 hours per day;
• Manifest cylinder less than or equal to 0.75 diopter (D) in each eye;
• Best corrected distance visual acuity better than or equal to 20/25 (Snellen) in each eye.

Key Exclusion Criteria:

• Current or prior habitual DAILIES TOTAL1 soft contact lens wear in the past 3 months prior to consent;
• Monovision contact lens wear;
• Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.

The safety analysis set included all subjects/eyes exposed to DAILIES TOTAL1 lenses evaluated in this study.

Adverse Events (AEs) were collected from time of consent to study exit, up to approximately 6 to 8 days of contact lens wear.

AEs were obtained through solicited and spontaneous comments from subjects and through observations by the investigator. "At Risk" population for ocular AEs is reported in units of eyes; all other populations are reported in units of subjects. This analysis population includes all subjects/eyes exposed to DAILIES TOTAL1 lenses evaluated in this study. The Other (Not Including Serious) Adverse Event table reports only the AEs that occurred above a 5% threshold in one or more reporting group.

In this single arm study, the subject will be masked to the lens type.